Author:
Kunanitthaworn Natchaya,Mueangmo Oramai,Saheng Jutamad,Wongjak Worawan,Lertsiriladakul Tanin,Chaito Tanachot,Nantarat Pasawat,Sudjaritruk Tavitiya
Abstract
AbstractThis cross-sectional study aimed to assess seroprevalence of hepatitis A virus (HAV) antibodies and identify factors associated with HAV seropositivity among children and adolescents aged 1–18 years who resided in Chiang Mai, Thailand. Sociodemographic characteristics, sanitation/hygiene, and history of HAV vaccination were collected. Anti-HAV IgG antibody was determined, and a level ≥ 1.0 S/CO defined HAV seropositivity. We enrolled 300 participants; median age 8.7 years, 54% male, and 13% overweight (BMI z-score: + 1 to + 2 standard deviation [SD]). Sixty-five participants (22%) were vaccinated against HAV. Overall, 84/300 participants (28%) demonstrated HAV seropositivity, of whom 55/65 (85%) and 29/235 (12%) were among vaccinated and unvaccinated participants (P < 0.001), respectively. Previous HAV vaccination (adjusted odds ratio [aOR] 47.2; 95% CI 20.0–111.8) and overweight (aOR 4.4; 95% CI 1.7–11.3, compared with normal weight [BMI z-score: − 2 to + 1 SD]) were significantly associated with seropositivity of HAV. In the stratified analyses, crowded bedroom (aOR 3.2; 95% CI 1.3–7.8, per one person increase) and overweight (aOR 5.0; 95% CI 1.8–13.7) were factors associated with HAV seropositivity among vaccinated and unvaccinated participants, respectively. Seroprevalence of HAV antibodies in healthy Thai children and adolescents was relatively low. Recommendation of HAV vaccination for these populations, particularly those with high-risk conditions, should be considered.
Funder
The Faculty of Medicine, Chiang Mai University Research Fund
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organization. WHO Immunological Basis for Immunization Series; Module 18: Hepatitis A (WHO, 2019).
2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases 14th edn. (Washington, D.C. Public Health Foundation, 2021).
3. Melnick, J. L. History and epidemiology of hepatitis A virus. J. Infect. Dis. 171(Suppl 1), S2–S8 (1995).
4. Jacobsen, K. H. & Koopman, J. S. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int. J. Epidemiol. 34(3), 600–609 (2005).
5. Jacobsen, K. H. & Koopman, J. S. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol. Infect. 132(6), 1005–1022 (2004).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献